Eli Lilly Gets Approval From FDA For Amyvid

Eli Lilly (NYSE:LLY) announced late Friday it received approval from the FDA for Amyvid, a diagnostic imaging agent that is aimed to assist diagnosing Alzheimer's disease and causes of cognitive decline.